ONCOARENDI THERAP ZY-,01/ PLONCTH00011 /
15/11/2024 21:43:32 | Chg. -0.0900 | Volume | Bid21:50:11 | Ask21:50:11 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.1200EUR | -4.07% | - Turnover: - |
1.9120Bid Size: 1,194 | 2.2750Ask Size: 1,194 | 35.49 mill.EUR | - | - |
Assets
|
2021 IFRS Units_1_Short PLN |
2022 IFRS Units_1_Short PLN |
2023 IFRS Units_1_Short PLN |
||||
---|---|---|---|---|---|---|---|
Property and Equipment | 3.99 mill. | 5.22 mill. | 3.46 mill. | ||||
Intangible Assets | 101,249 | 256,297 | 361,176 | ||||
Long-Term Investments | - | - | - | ||||
Fixed Assets | 35.65 mill. | 16.83 mill. | 46.56 mill. | ||||
Inventories | - | - | - | ||||
Accounts Receivable | 1.45 mill. | 2.51 mill. | 1.72 mill. | ||||
Cash and Cash Equivalents | 102.03 mill. | 65.62 mill. | 63.99 mill. | ||||
Current Assets | 115.94 mill. | 74.99 mill. | 65.71 mill. | ||||
Total Assets | 151.58 mill. | 91.82 mill. | 112.27 mill. |
Liabilities
|
2021 IFRS Units_1_Short PLN |
2022 IFRS Units_1_Short PLN |
2023 IFRS Units_1_Short PLN |
||||
---|---|---|---|---|---|---|---|
Accounts Payable | 1.99 mill. | 2.82 mill. | 3.02 mill. | ||||
Long-term debt | - | - | - | ||||
Liabilities to Banks | - | - | - | ||||
Provisions | 1.09 mill. | 724,662 | 806,763 | ||||
Liabilities | 10.43 mill. | 11.61 mill. | 11.34 mill. | ||||
Share Capital | - | - | - | ||||
Total Equity | 141.15 mill. | 80.21 mill. | 100.93 mill. | ||||
Minority Interests | - | - | - | ||||
Total liabilities equity | 151.58 mill. | 91.82 mill. | 112.27 mill. |
Income Statement
|
2021 IFRS Units_1_Short PLN |
2022 IFRS Units_1_Short PLN |
2023 IFRS Units_1_Short PLN |
||||
---|---|---|---|---|---|---|---|
Revenues | 1.17 mill. | 7.51 mill. | 3.65 mill. | ||||
Depreciation (total) | 299,817 | 3.98 mill. | 2.83 mill. | ||||
Operating Result | -13.24 mill. | -37.67 mill. | -32.18 mill. | ||||
Interest Income | 127,980 | 1.72 mill. | 3.81 mill. | ||||
Income Before Taxes | - | - | - | ||||
Income Taxes | - | - | - | ||||
Minority Interests Profit | - | - | - | ||||
Net Income | -13.37 mill. | -35.95 mill. | -28.37 mill. |
Per Share
Cash Flow
|
2021 IFRS Units_1_Short PLN |
2022 IFRS Units_1_Short PLN |
2023 IFRS Units_1_Short PLN |
||||
---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -12.98 mill. | -34.13 mill. | -23.29 mill. | ||||
Cash Flow from Investing Activities | -19.08 mill. | -9.99 mill. | -33.87 mill. | ||||
Cash Flow from Financing | 13.85 mill. | 7.7 mill. | 55.53 mill. | ||||
Decrease / Increase in Cash | - | - | - | ||||
Employees | 89 | 107 | 112 |